“Tumor Response to Combination Celecoxib and Erlotinib Therapy in Non-Small Cell ... Calcinai, E. Samaritani, et al., “Tumour Necrosis Factor-Alpha and Transforming Growth Factor-Beta Are ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

A new study published in the journal of Cureus showed that nearly three out of four psoriasis patients had dyslipidemia, ...

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis of tumor cells but not most normal cells. Its roles in normal nontransformed tissues are not clear.

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

A study published in the Journal of Cosmetic Dermatology explores the potential of Djon Djon, a unique mushroom fermented by ...

Dr. John Cacioppo, the world’s leading social isolation researcher. His statement sounds loud in the ear when you take i ...

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 52 , 1766–1772 (2005).